Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01104103 · ClinicalTrials.gov registry record · NA

Effectiveness Study of the BOA(R)-Constricting IV Band

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Terminated
Registry status
NA
Development phase
467
Enrollment target

NCT01104103: Clinical Trial NA study, sponsored by The University of Texas Health Science Center, Houston.

NCT01104103 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 467 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01104103, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.

TERMINATED
Registry status
NA
Development phase
467 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether the BOA(R)-Constricting IV Band is superior to standard methods for starting an IV.

Primary Outcome

This outcome will measure self-reported success at starting the peripheral intravenous lines in the upper extremity of adults. Success is defined as an IV line through which blood may be aspirated and flushes freely without evidence of fluid extravasation. To be successful, the IV must be placed within a maximum of three attempts. We will report the number and percentage of patients with successful for both therapies.

Interventions

  • DEVICE BOA(R)-Constricting IV Band
  • DEVICE Standard elastic constricting band

Trial Details

FieldValue
Enrollment Target 467 participants
Start Date 2010-03
Est. Completion 2010-05
Phase NA

Why NCT01104103 stopped before completion

NCT01104103 is an interventional study that assigns participants to a tested intervention. The registered 467 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).

The record links to 0 conditions, and to 2 interventions - of which BOA(R)-Constricting IV Band is the first listed.

NCT01104103 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01104103 about?

NCT01104103 is a clinical study titled "Effectiveness Study of the BOA(R)-Constricting IV Band". The purpose of this study is to determine whether the BOA(R)-Constricting IV Band is superior to standard methods for starting an IV.

What is the current status of trial NCT01104103?

This trial is currently terminated. It is a NA study. The enrollment target is 467 participants. The study started on 2010-03. Estimated completion is 2010-05.

What interventions are being tested in trial NCT01104103?

The interventions under investigation include: BOA(R)-Constricting IV Band (DEVICE), Standard elastic constricting band (DEVICE).

Who is sponsoring clinical trial NCT01104103?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01104103's enrollment target sits among peer trials

467 222nd of 2000 higher than 1,779 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06456554 · 467 participants · NA

    Acellular Dermal Matrix Investigation in Breast Reconstruction

  • NCT03124303 · 468 participants

    Interventions for Postoperative Delirium: Biomarker-3

  • NCT03901924 · 468 participants · NA

    Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy

  • NCT04482309 · 468 participants · Phase 2

    A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01104103, the US trial registry maintained by the National Library of Medicine. NCT01104103 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.